.
MergerLinks Header Logo

Announced

CPPIB to invest $100m in Chi-Med.

Financials

Edit Data
Transaction Value£75m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Public

Friendly

Acquisition

Private Equity

Minority

Pending

Single Bidder

Cross Border

Hong Kong

Pharmaceuticals

biopharmaceuticals

Synopsis

Edit

Canada Pension Plan Investment Board, a global investment management organization, is set to invest $100m in Chi-Med, a developer, manufacturer, and distributor pharmaceutical products. “This placement aligns with CPP Investments’ focus on providing strategic, long-term capital to industry leading companies where we can participate in the future success of the business and help create greater value through ongoing partnership. We look forward to supporting Chi-Med’s work on innovation in oncology treatment," Agus Tandiono, CPPIB Managing Director and Head of Fundamental Equities Asia.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US